Moderna gains fresh market attention after a unanimous flu vaccine panel vote strengthens confidence in its mRNA vaccine ...
Moderna Inc. Chief Executive Officer Stephane Bancel said he sees the pending launch of a planned flu vaccine as a chance to ...
FDA Advisors Back Moderna's mRNA Flu Vaccine Unanimously: The Biggest Healthcare Move of Summer 2026
Your resource for the hottest moving stocks and news. We cover all sectors and markets giving everyday investors access to ...
Asianet Newsable on MSN
mRNA stock rallies over 40% in June: Moderna bets its future on cancer, autoimmune disease and AI-powered mRNA
Cancer was a key focus, with programs targeting solid tumors, Lynch syndrome, melanoma, and non-small cell lung cancer.
AI and mRNA drive cancer vaccine gains as MSD, Moderna cut melanoma relapse Personalized melanoma shot from Msd and Moderna ...
A federal vaccine advisory panel today gave its stamp of approval to Moderna’s mRNA influenza vaccine (mRNA-1010) for older ...
Moderna’s mRNA-centric business is in conflict with the U.S. government’s shifting views on mRNA technology, and analysts say that’s a risk. The biotech announced Tuesday evening that in a rare move, ...
MarketBeat on MSN
Short Squeeze Alert-Moderna Stock Surges on New Strategy
Key Points Interested in Moderna, Inc.? Here are five stocks we like better. Moderna shares rose nearly 20% after Science Day ...
In a large-scale trial, modRNA was significantly better at preventing confirmed flu cases than a typical seasonal flu shot. Reading time 3 minutes Next-generation vaccines could make the flu season ...
Moderna just received fantastic news.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results